Protein microarray platforms for clinical proteomics
暂无分享,去创建一个
Harvey B Pollard | D. Jacobowitz | C. Paweletz | O. Eidelman | H. Pollard | M. Srivastava | W. Guggino | P. Zeitlin | C. Jozwik | T. Darling | Cloud P Paweletz | Meera Srivastava | Ofer Eidelman | Catherine Jozwik | Pamela L Zeitlin | William B Guggino | S. Rothwell | Stephen W Rothwell | Gregory P Mueller | David M Jacobowitz | Thomas Darling | Jerry Wright | Jerry M. Wright | G. Mueller | Gregory Mueller | Gregory P. Mueller
[1] Mauro Ferrari,et al. Physicochemically modified silicon as a substrate for protein microarrays. , 2007, Biomaterials.
[2] Jonathan S. Reichner,et al. Antibodies Immobilized as Arrays to Profile Protein Post-translational Modifications in Mammalian Cells* , 2004, Molecular & Cellular Proteomics.
[3] J. Mccoy,et al. A plasmid expression system for quantitative in vivo biotinylation of thioredoxin fusion proteins in Escherichia coli. , 1998, Nucleic acids research.
[4] E. Tan,et al. Autoantibodies in the diagnosis of systemicrheumatic diseases , 1995 .
[5] Rainer Breitling,et al. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.
[6] G. P. Smith,et al. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.
[7] F. F. Madrid,et al. Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis. , 2005 .
[8] Virginia Espina,et al. Proteomic Analysis of Apoptotic Pathways Reveals Prognostic Factors in Follicular Lymphoma , 2005, Clinical Cancer Research.
[9] Ioan Tabus,et al. Robust estimation of protein expression ratios with lysate microarray technology , 2005, Bioinform..
[10] Jian Zhang,et al. Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[11] K. Jacobson,et al. Amphiphilic pyridinium salts block TNF alpha/NF kappa B signaling and constitutive hypersecretion of interleukin-8 (IL-8) from cystic fibrosis lung epithelial cells. , 2005, Biochemical pharmacology.
[12] Emanuel F Petricoin,et al. Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays , 2003, Proteomics.
[13] S. Schreiber,et al. Printing proteins as microarrays for high-throughput function determination. , 2000, Science.
[14] F W Chu,et al. Multianalyte microspot immunoassay--microanalytical "compact disk" of the future. , 1991, Clinical chemistry.
[15] G. Fuller,et al. Overexpression of IGFBP5, but not IGFBP3, Correlates with the Histologic Grade of Human Diffuse Glioma: A Tissue Microarray and Immunohistochemical Study , 2006, Technology in cancer research & treatment.
[16] M. Taussig,et al. Single step generation of protein arrays from DNA by cell-free expression and in situ immobilisation (PISA method). , 2001, Nucleic acids research.
[17] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Jongsma,et al. Self‐assembling protein arrays on DNA chips by auto‐labeling fusion proteins with a single DNA address , 2006, Proteomics.
[19] T. Barrette,et al. Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. , 2001, Cancer research.
[20] A. Plückthun,et al. High-affinity binders selected from designed ankyrin repeat protein libraries , 2004, Nature Biotechnology.
[21] Erik K. Malm,et al. A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics* , 2005, Molecular & Cellular Proteomics.
[22] Johan Ingvarsson,et al. Microarrays based on affinity‐tagged single‐chain Fv antibodies: Sensitive detection of analyte in complex proteomes , 2005, Proteomics.
[23] M. Vaysberg,et al. Autoantigen arrays for multiplex analysis of antibody isotypes , 2006, Proteomics.
[24] Jennifer E. Van Eyk,et al. Clinical proteomics : from diagnosis to therapy , 2007 .
[25] N. Socci,et al. Profiling bladder cancer using targeted antibody arrays. , 2006, The American journal of pathology.
[26] M. Snyder,et al. Analyzing antibody specificity with whole proteome microarrays , 2003, Nature Biotechnology.
[27] Prem Gurnani,et al. Pegylated, steptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays. , 2005, Bioconjugate chemistry.
[28] D. Jacobowitz,et al. De Novo Biosynthetic Profiling of High Abundance Proteins in Cystic Fibrosis Lung Epithelial Cells*S , 2006, Molecular & Cellular Proteomics.
[29] Ian B. Jeffery,et al. Comparison and evaluation of methods for generating differentially expressed gene lists from microarray data , 2006, BMC Bioinformatics.
[30] Jørgen Kjems,et al. Cantilever sensor for nanomechanical detection of specific protein conformations. , 2005, Nano letters.
[31] H. Lehrach,et al. Next generation of protein microarray support materials: evaluation for protein and antibody microarray applications. , 2003, Journal of chromatography. A.
[32] S. Kingsmore,et al. Multiplexed protein profiling on microarrays by rolling-circle amplification , 2002, Nature Biotechnology.
[33] Jeffrey A. Bluestone,et al. In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.
[34] P. Cuatrecasas,et al. The purification of beta-galactosidase from Escherichia coli by affinity chromatography. , 1971, The Journal of biological chemistry.
[35] RAINER BREITLING,et al. Rank-based Methods as a Non-parametric Alternative of the T-statistic for the Analysis of Biological Microarray Data , 2005, J. Bioinform. Comput. Biol..
[36] Wei Huang,et al. Serum proteomic signature for cystic fibrosis using an antibody microarray platform. , 2006, Molecular genetics and metabolism.
[37] F. von Eggeling,et al. Detection and identification of heat shock protein 10 as a biomarker in colorectal cancer by protein profiling , 2006, Proteomics.
[38] N. Anderson,et al. The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.
[39] Sophia Hober,et al. Microfluidic analysis of antibody specificity in a compact disk format. , 2006, Journal of proteome research.
[40] Gesine Hansen,et al. Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma. , 2005, Lung cancer.
[41] E. Petricoin,et al. Signal pathway profiling of prostate cancer using reverse phase protein arrays , 2003, Proteomics.
[42] J. Hartley,et al. Cardiac glycosides inhibit TNF-α/NF-κB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor , 2005 .
[43] S. Sakaguchi. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.
[44] Pierre Baldi,et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[45] R. Christopherson,et al. Multiplex detection of surface molecules on colorectal cancers , 2006, Proteomics.
[46] E. Petricoin,et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front , 2001, Oncogene.
[47] Paul J Utz,et al. Protein microarrays for multiplex analysis of signal transduction pathways , 2004, Nature Medicine.
[48] Gavin MacBeath,et al. State-based discovery: a multidimensional screen for small-molecule modulators of EGF signaling , 2006, Nature Methods.
[49] A. Butte,et al. Multiplexed protein array platforms for analysis of autoimmune diseases. , 2006, Annual review of immunology.
[50] C. Schaefer,et al. Analysis of the human serum proteome , 2004, Clinical Proteomics.
[51] G. A. Whitmore,et al. Nonparametric Methods for Microarray Data Based on Exchangeability and Borrowed Power , 2005, Journal of biopharmaceutical statistics.
[52] A Coldman,et al. Evaluation of immunohistochemical markers in non‐small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers , 2004, The Journal of pathology.
[53] Bhupinder Bhullar,et al. Self-Assembling Protein Microarrays , 2004, Science.
[54] O. Kallioniemi,et al. ANX7, a candidate tumor suppressor gene for prostate cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[55] R. Bangham,et al. Protein microarrays: a new tool for profiling antibody cross-reactivity. , 2006, Human antibodies.
[56] Dieter Stoll,et al. A microarray enzyme‐linked immunosorbent assay for autoimmune diagnostics , 2000, Electrophoresis.
[57] P. Sorger,et al. Profiling receptor tyrosine kinase activation by using Ab microarrays , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[58] M. Ladisch,et al. Anomalous resonance in a nanomechanical biosensor , 2006, Proceedings of the National Academy of Sciences.
[59] Paolo Visca,et al. Tissue microarray analysis of FAS, Bcl-2, Bcl-x, ER, PgR, Hsp60, p53 and Her2-neu in breast carcinoma. , 2006, Anticancer research.
[60] I. Gromova,et al. Identification of Extracellular and Intracellular Signaling Components of the Mammary Adipose Tissue and Its Interstitial Fluid in High Risk Breast Cancer Patients , 2005, Molecular & Cellular Proteomics.
[61] E. Tan,et al. Tumor-associated Antigen Arrays for the Serological Diagnosis of Cancer* , 2006, Molecular & Cellular Proteomics.
[62] Yoonsuk Lee,et al. ProteoChip: A highly sensitive protein microarray prepared by a novel method of protein immobilization for application of protein‐protein interaction studies , 2003, Proteomics.
[63] Russ B. Altman,et al. Nonparametric methods for identifying differentially expressed genes in microarray data , 2002, Bioinform..
[64] Brian B Haab,et al. Antibody Arrays in Cancer Research , 2005, Molecular & Cellular Proteomics.
[65] Serge Muyldermans,et al. Efficient cancer therapy with a nanobody-based conjugate. , 2004, Cancer research.
[66] P. Brown,et al. Autoantigen microarrays for multiplex characterization of autoantibody responses , 2002, Nature Medicine.
[67] Eun Jeong Cho,et al. Production and processing of aptamer microarrays. , 2005, Methods.
[68] Brian B Haab,et al. Applications of antibody array platforms. , 2006, Current opinion in biotechnology.
[69] H. Lehrach,et al. A Nonredundant Human Protein Chip for Antibody Screening and Serum Profiling* , 2003, Molecular & Cellular Proteomics.
[70] David E. Misek,et al. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis , 2005, BMC Cancer.
[71] M. Taussig,et al. DiscernArray technology: a cell-free method for the generation of protein arrays from PCR DNA. , 2003, Journal of immunological methods.
[72] M. Uhlén,et al. Affibody molecules in protein capture microarrays: evaluation of multidomain ligands and different detection formats. , 2007, Journal of proteome research.
[73] J. Stone,et al. HLA-restricted epitope identification and detection of functional T cell responses by using MHC-peptide and costimulatory microarrays. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[74] B. Hahn. Antibodies to DNA. , 1998, The New England journal of medicine.
[75] K. Jacobson,et al. Amphiphilic pyridinium salts block TNFα/NFκB signaling and constitutive hypersecretion of interleukin-8 (IL-8) from cystic fibrosis lung epithelial cells , 2005 .
[76] D. Jacobowitz,et al. High abundance protein profiling of cystic fibrosis lung epithelial cells , 2005, Proteomics.
[77] E. Koay,et al. Overexpression of CC3/TIP30 is associated with HER-2/neu status in breast cancer , 2005, Journal of Cancer Research and Clinical Oncology.
[78] E. B. Butler,et al. Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers , 2003, Proteomics.
[79] O. Kallioniemi,et al. Prognostic Impact of ANX7-GTPase in Metastatic and HER2-Negative Breast Cancer Patients , 2004, Clinical Cancer Research.
[80] P. Andersson,et al. Simultaneous multiple immunoassays in a compact disc-shaped microfluidic device based on centrifugal force. , 2005, Clinical chemistry.
[81] D. Cummins,et al. Multiplex proteomic approaches to sepsis research: case studies employing new technologies , 2005, Expert review of proteomics.
[82] 勇人 伊古田. Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology , 2007 .
[83] Jürgen Kreutzberger,et al. Generation of High Density Protein Microarrays by Cell-free in Situ Expression of Unpurified PCR Products * , 2006, Molecular & Cellular Proteomics.
[84] David D. Nolte,et al. Scaling mass sensitivity of the BioCD at 0.25 pg/mm , 2006, SPIE Optics East.
[85] C. J. Anderson,et al. Development of the anti-ribosomal P autoantibody response. , 1998, Clinical and experimental rheumatology.
[86] R Ekins,et al. High specific activity chemiluminescent and fluorescent markers: their potential application to high sensitivity and 'multi-analyte' immunoassays. , 1989, Journal of bioluminescence and chemiluminescence.
[87] Li Ni,et al. A procedure for assessing GO annotation consistency , 2005, ISMB.
[88] Thomas Kodadek,et al. Protein "fingerprinting" in complex mixtures with peptoid microarrays. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[89] P. Peluso,et al. Optimizing antibody immobilization strategies for the construction of protein microarrays. , 2003, Analytical biochemistry.
[90] Dao-Hai Zhang,et al. Proteomics of breast cancer: Enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors , 2005, Proteomics.
[91] Byung-Chun Kim,et al. Average Bioequivalence for Two-Sequence Two-Period Crossover Design with Incomplete Data , 2005, Journal of biopharmaceutical statistics.
[92] Bonnie Bruce,et al. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. , 2005, Arthritis and rheumatism.
[93] Ioan Tabus,et al. Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays , 2006, Proteomics.
[94] S. Muyldermans,et al. Single domain camel antibodies: current status. , 2001, Journal of biotechnology.
[95] Yan Li,et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus , 2007, Nature.
[96] M. Gerstein,et al. Global Analysis of Protein Activities Using Proteome Chips , 2001, Science.
[97] E. Petricoin,et al. Kinase substrate protein microarray analysis of human colon cancer and hepatic metastasis. , 2005, Clinica chimica acta; international journal of clinical chemistry.
[98] D. Jacobowitz,et al. Pooled ORF Expression Technology (POET) , 2005, Molecular & Cellular Proteomics.
[99] Yiling Lu,et al. Use of Reverse Phase Protein Microarrays and Reference Standard Development for Molecular Network Analysis of Metastatic Ovarian Carcinoma* , 2005, Molecular & Cellular Proteomics.
[100] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[101] JOSEPH G. FEINBERG,et al. A ‘Microspot’ Test for Antigens and Antibodies , 1961, Nature.
[102] Harvey B Pollard,et al. Pharmacoproteomics of 4-phenylbutyrate-treated IB3-1 cystic fibrosis bronchial epithelial cells. , 2006, Journal of proteome research.
[103] G. Mills,et al. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells , 2006, Molecular Cancer Therapeutics.
[104] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[105] E. Jaffe,et al. In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. , 2002, Blood.
[106] J. Hartley,et al. Cardiac glycosides inhibit TNF-alpha/NF-kappaB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[107] Joakim Lundeberg,et al. Serum Microarrays for Large Scale Screening of Protein Levels *S , 2005, Molecular & Cellular Proteomics.
[108] Emanuel Petricoin,et al. Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray , 2004, Laboratory Investigation.
[109] Barry Smith,et al. Quality control for terms and definitions in ontologies and taxonomies , 2006, BMC Bioinformatics.
[110] L. Mayr,et al. Evaluation of two novel tag-based labelling technologies for site-specific modification of proteins. , 2006, International journal of biological macromolecules.
[111] Andrea Crisanti,et al. Antigen microarrays for serodiagnosis of infectious diseases. , 2002, Clinical chemistry.
[112] P. Brown,et al. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions , 2001, Genome Biology.
[113] William C Reinhold,et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[114] J G FEINBERG,et al. Detection of auto-immune antibody and tissue antigens by the `microspot' technique , 1963, Journal of clinical pathology.
[115] A. Partin,et al. Antibody array profiling reveals serum TSP‐1 as a marker to distinguish benign from malignant prostatic disease , 2007, The Prostate.
[116] R. L. Grubbs,et al. Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis* , 2004, Critical care medicine.
[117] A. Gown,et al. p63 Expression in Lung Carcinoma: A Tissue Microarray Study of 408 Cases , 2004, Applied immunohistochemistry & molecular morphology : AIMM.